bone disease, Primary Sclerosing Cholangitis Literature

Primary Sclerosing Cholangitis Literature

Home Page

FAQ

PSC Partners

www Resources

Scientific Literature

Scientific Literature, bone disease

Abadia-Molina AC, Ji H, Faubion WA, Julien A, Latchman Y, Yagita H, Sharpe A, Bhan AK, Terhorst C 2006 CD48 controls T cell and antigen-presenting cell functions in experimental colitis. Gastroenterology 130: 424-434. *
Abadia-Molina AC, Mizoguchi A, Faubion WA, De Jong YP, Rietdijk ST, Comiskey M, Clarke K, Bhan AK, Terhorst C 2005 In vivo generation of oligoclonal colitic CD4+ T-cell lines expressing a distinct T-cell receptor Vbeta. Gastroenterology 128: 1268-1277. *
Abazis-Stamboulieh D, Oikonomou P, Papadoulis N, Panayiotidis P, Vrakidou E, Tsezou A 2007 Association of interleukin-1A, interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms with multiple myeloma. Leuk. Lymphoma 48: 2196-2203.
Abdul-Hai A, Hershkoviz R, Weiss L, Lider O, Slavin S 2005 Effect of linomide on adhesion molecules, TNF-alpha, nitrogen oxide, and cell adhesion. Int. Immunopharmacol. 5: 231-239.
Abe M, Thomson AW 2006 Dexamethasone preferentially suppresses plasmacytoid dendritic cell differentiation and enhances their apoptotic death. Clin. Immunol. 118: 300-306. *
Abitbol V, Briot K, Roux C, Roy C, Seksik P, Charachon A, Bouhnik Y, Coffin B, Allez M, Lamarque D, Chaussade S 2007 A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 5: 1184-1189.
Abitbol V, Mary JY, Roux C, Soule JC, Belaiche J, Dupas JL, Gendre JP, Lerebours E, Chaussade S; Groupe D'etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID) 2002 Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride. Aliment. Pharmacol. Ther. 16: 919-927. *
Abitbol V, Roux C, Chaussade S, Guillemant S, Kolta S, Dougados M, Couturier D, Amor B 1995 Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 108: 417-422. *
Ablin JN, Goldstein Z, Aloush V, Matz H, Elkayam O, Caspi D, Swartzenberg S, George J, Wohl Y 2008 Normal levels and function of endothelial progenitor cells in patients with psoriatic arthritis. Rheumatol. Int. Aug 15 [Epub ahead of print]. *
Abramson SB, Amin A 2002 Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage. Rheumatology (Oxford) 41: 972-980. *
Abramson SB, Yazici Y 2006 Biologics in development for rheumatoid arthritis: relevance to osteoarthritis. Adv. Drug Deliv. Rev. 58: 212-225. *
Abreu MT 2005 Effectiveness of controlled-release budesonide in preserving bone mineral density in patients with Crohn's disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 210-211. *
Abreu MT, Geller JL, Vasiliauskas EA, Kam LY, Vora P, Martyak LA, Yang H, Hu B, Lin YC, Keenan G, Price J, Landers CJ, Adams JS, Targan SR 2006 Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn's disease. J. Clin. Gastroenterol. 40: 55-63.
Abreu MT, Kantorovich V, Vasiliauskas EA, Gruntmanis U, Matuk R, Daigle K, Chen S, Zehnder D, Lin YC, Yang H, Hewison M, Adams JS 2004 Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density. Gut 53: 1129-1136. *
Abreu MT, Yang H 2004 Is genetic testing in IBD ready for prime time? Am. J. Gastroenterol. 99: 316-318. *
Abu-Amer Y, Darwech I, Otero J 2008 Role of the NF-kappaB axis in immune modulation of osteoclasts and bone loss. Autoimmunity 41: 204-211.
Abuzakouk M, Barnes L, O'Gorman N, O'Grady A, Mohamed B, McKenna MJ, Freaney R, Feighery C 2007 Dermatitis herpetiformis: no evidence of bone disease despite evidence of enteropathy. Dig. Dis. Sci. 52: 659-664. *
Achkar JP, Dassopoulos T, Silverberg MS, Tuvlin JA, Duerr RH, Brant SR, Siminovitch K, Reddy D, Datta LW, Bayless TM, Zhang L, Barmada MM, Rioux JD, Steinhart AH, McLeod RS, Griffiths AM, Cohen Z, Yang H, Bromfield GP, Schumm P, Hanauer SB, Cho JH, et al 2006 Phenotype-stratified genetic linkage study demonstrates that IBD2 is an extensive ulcerative colitis locus. Am. J. Gastroenterol. 101: 572-580. *
Ackert-Bicknell C, Rosen C 2006 The genetics of PPARG and the skeleton. PPAR Res. 2006: 93258. *
Adachi JD, Rostom A 1999 Metabolic bone disease in adults with inflammatory bowel disease. Inflamm. Bowel Dis. 5: 200-211.
Adorini L 2002 Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int. Immunopharmacol. 2: 1017-1028.
Adorini L, Penna G 2008 Control of autoimmune diseases by the vitamin D endocrine system. Nat. Clin. Pract. Rheumatol. 4: 404-412.
Adriaansen J, Kuhlman RR, Holten JV, Kaynor C, Vervoordeldonk MJ, Tak PP 2006 Intraarticular interferon-beta gene therapy ameliorates adjuvant arthritis in rats. Hum. Gene Ther. 17: 985-996.
Afdhal N, McHutchison J, Brown R, Jacobson I, Manns M, Poordad F, Weksler B, Esteban R 2008 Thrombocytopenia associated with chronic liver disease. J. Hepatol. 48: 1000-1007. *
Afonso V, Champy R, Mitrovic D, Collin P, Lomri A 2007 Reactive oxygen species and superoxide dismutases: role in joint diseases. Joint Bone Spine 74: 324-329.
Agarwal N, Puri AS, Grover R 2007 Non-diarrheal celiac disease: a report of 31 cases from Northern India. Indian J. Gastroenterol. 26: 122-126. *
Aggarwal BB 2003 Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3: 745-756. *
Aggarwal P, Aggarwal A, Gupta S, Misra R 2006 Osteopenia is common in adult male patients with active juvenile idiopathic arthritis. J. Rheumatol. 33: 1642-1645.
Aghdami N, Gharibdoost F, Moazzeni SM 2008 Experimental autoimmune encephalomyelitis (EAE) induced by antigen pulsed dendritic cells in the C57BL/6 mouse: influence of injection route. Exp. Anim. 57: 45-55.
Aguirre S, Silber AM, Brito ME, Ribone ME, Lagier CM, Marcipar IS 2006 Design, construction, and evaluation of a specific chimeric antigen to diagnose chagasic infection. J. Clin. Microbiol. 44: 3768-3774. *
Ahluwalia M, Gotlieb V, Damerla V, Saif MW 2006 Aggressive Burkitt-like lymphoma of colon in a patient with prior celiac disease. Yale J. Biol. Med. 79: 173-175. *
Ahmed SF, Horrocks IA, Patterson T, Zaidi S, Ling SC, McGrogan P, Weaver LT 2004 Bone mineral assessment by dual energy X-ray absorptiometry in children with inflammatory bowel disease: evaluation by age or bone area. J. Pediatr. Gastroenterol. Nutr. 38: 276-280. *
Ahmed SF, Wong JS, McGrogan P 2007 Improving growth in children with inflammatory bowel disease. Horm. Res. 68 Suppl. 5: S117-S121.
Ahn SC, Kim GY, Kim JH, Baik SW, Han MK, Lee HJ, Moon DO, Lee CM, Kang JH, Kim BH, Oh YH, Park YM 2004 Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-kappaB. Biochem. Biophys. Res. Commun. 313: 148-155. *
Akabane H, Miyagawa N, Nii H, Inami Y, Togawa M, Tanaka H, Inagaki N, Nagai H 2004 The effect of a newly synthesized indazole compound, TAS-3-124, on experimental autoimmune disease. Biol. Pharm. Bull. 27: 1218-1223. *
Akhter MP, Jung LK 2007 Decreased bone strength in HLA-B27 transgenic rat model of spondyloarthropathy. Rheumatology (Oxford) 46: 1258-1262. *
Akkari V, Donadieu J, Piguet C, Bordigoni P, Michel G, Blanche S, Casanova JL, Thomas C, Vilmer E, Fischer A, Bertrand Y; French Langerhans Cell Study Group 2003 Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: experience of the French Langerhans Cell Study Group. Bone Marrow Transplant. 31: 1097-1103.
Al-Salleeh F, Petro TM 2008 Promoter analysis reveals critical roles for SMAD-3 and ATF-2 in expression of IL-23 p19 in macrophages. J. Immunol. 181: 4523-4533.
Alaez C, Loyola M, Murguia A, Flores H, Rodriguez A, Ovilla R, Ignacio G, Amador R, Salinas V, Perez F, Rodriguez D, Morales Z, Llinguin G, Vazquez A, Altamirano A, Gorodezky C 2006 Hematopoietic stem cell transplantation (HSCT): an approach to autoimmunity. Autoimmun. Rev. 5: 167-179.
Alajlan A, Alfadley A, Pedersen KT 2002 Transfer of vitiligo after allogeneic bone marrow transplantation. J. Am. Acad. Dermatol. 46: 606-610.
Alderuccio F, Murphy K, Biondo M, Field J, Toh BH 2005 Reversing the autoimmune condition: experience with experimental autoimmune gastritis. Int. Rev. Immunol. 24: 135-155.
Alderuccio F, Toh BH 2004 Induction of tolerance to self-antigens using genetically modified bone marrow cells. Expert Opin. Biol. Ther. 4: 1007-1014.
Ali MS, Pearson JP 2007 Upper airway mucin gene expression: a review. Laryngoscope 117: 932-938.
Allanore Y, Batteux F, Avouac J, Assous N, Weill B, Kahan A 2007 Levels of circulating endothelial progenitor cells in systemic sclerosis. Clin. Exp. Rheumatol. 25: 60-66.
Allen KJ, Cheah DM, Lee XL, Pettigrew-Buck NE, Vadolas J, Mercer JF, Ioannou PA, Williamson R 2004 The potential of bone marrow stem cells to correct liver dysfunction in a mouse model of Wilson's disease. Cell Transplant. 13: 765-773.
Alley RA, Chen EL, Beyer TD, Prinz RA 2008 Does homocysteine contribute to bone disease in hyperparathyroidism? Am. J. Surg. 195: 374-377.
Alli R, Nguyen P, Geiger TL 2008 Retrogenic modeling of experimental allergic encephalomyelitis associates T cell frequency but not TCR functional affinity with pathogenicity. J. Immunol. 181: 136-145.
Allocca M, Crosignani A, Benetti A, Battezzati PM 2007 Bone disease in primary biliary cirrhosis and renal tubular acidosis: authors' reply. Aliment. Pharmacol. Ther. 25: 1134. *
Allocca M, Crosignani A, Gritti A, Benetti A, Zuin M, Podda M, Battezzati PM 2007 Inadequate dietary intake but not renal tubular acidosis is associated with bone demineralization in primary biliary cirrhosis. Aliment. Pharmacol. Ther. 25: 219-227. *
Almehed K, Forsblad d'Elia H, Kvist G, Ohlsson C, Carlsten H 2007 Prevalence and risk factors of osteoporosis in female SLE patients - extended report. Rheumatology (Oxford) 46: 1185-1190. *
Almeida AR, Legrand N, Papiernik M, Freitas AA 2002 Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J. Immunol. 169: 4850-4860. *
Alnounou M, Munoz SJ 2006 Nutrition Issues In Gastroenterology, Series #37. Nutrition concerns of the patient with primary biliary cirrhosis or primary sclerosing cholangitis. [http://www.healthsystem.virginia.edu/internet/digestive-health/nutritionarticles/April2006.pdf] Practical Gastroenterology April 2006: 92-100. *
Alpers DH 2002 The role of nutritional deficiency in the osteopenia and osteoporosis of gastrointestinal diseases. Curr. Opin. Gastroenterol. 18: 203-208.
Alpoz E, Cankaya H, Guneri P 2007 Facial subcutaneous calcinosis and mandibular resorption in systemic sclerosis: a case report. Dentomaxillofac. Radiol. 36: 172-174.
Alsaadi G, Quirynen M, Komarek A, van Steenberghe D 2008 Impact of local and systemic factors on the incidence of late oral implant loss. Clin. Oral Implants Res. 19: 670-676.
Alsaadi G, Quirynen M, Komarek A, van Steenberghe D 2007 Impact of local and systemic factors on the incidence of oral implant failures, up to abutment connection. J. Clin. Periodontol. 34: 610-617.
Alsaadi G, Quirynen M, Michiles K, Teughels W, Komarek A, van Steenberghe D 2008 Impact of local and systemic factors on the incidence of failures up to abutment connection with modified surface oral implants. J. Clin. Periodontol. 35: 51-57.
Alsaeid K, Alawadhi A, Al-Saeed O, Haider MZ 2006 Human leukocyte antigen DRB1*04 is associated with rheumatoid arthritis in Kuwaiti patients. Joint Bone Spine 73: 62-65.
Amano K, Leung PS, Xu Q, Marik J, Quan C, Kurth MJ, Nantz MH, Ansari AA, Lam KS, Zeniya M, Coppel RL, Gershwin ME 2004 Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible. J. Immunol. 172: 6444-6452. *
Ambrogini E, Toraldo G, Marcocci C 2005 Post-menopausal osteoporosis: is it an autoimmune disease? J. Endocrinol. Invest. 28: S43-S47.
Anandarajah AP, Schwarz EM 2006 Anti-RANKL therapy for inflammatory bone disorders: mechanisms and potential clinical applications. J. Cell. Biochem. 97: 226-232. *
Andersen MH, Schrama D, Thor Straten P, Becker JC 2006 Cytotoxic T cells. J. Invest. Dermatol. 126: 32-41. *
Andreassen H, Rix M, Brot C, Eskildsen P 1998 Regulators of calcium homeostasis and bone mineral density in patients with Crohn's disease. Scand. J. Gastroenterol. 33: 1087-1093. *
Andreassen H, Rungby J, Dahlerup JF, Mosekilde L 1997 Inflammatory bowel disease and osteoporosis. Scand. J. Gastroenterol. 32: 1247-1255.
Andress DL 2006 Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int. 69: 33-43. *
Angulo P 2002 Use of ursodeoxycholic acid in patients with liver disease. Curr. Gastroenterol. Rep. 4: 37-44.
Angulo P, Therneau TM, Jorgensen A, DeSotel CK, Egan KS, Dickson ER, Hay JE, Lindor KD 1998 Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression. J. Hepatol. 29: 729-735. *
Annaloro C, Usardi P, Airaghi L, Giunta V, Forti S, Orsatti A, Baldini M, Delle Volpe A, Lambertenghi Deliliers G 2008 Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant. 41: 797-804.
Aprahamian T, Bonegio R, Rizzo J, Perlman H, Lefer DJ, Rifkin IR, Walsh K 2006 Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model. J. Immunol. 177: 3028-3034. *
Ardizzone S, Bollani S, Bettica P, Bevilacqua M, Molteni P, Bianchi Porro G 2000 Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis. J. Intern. Med. 247: 63-70. *
Arend WP 2002 The mode of action of cytokine inhibitors. J. Rheumatol. Suppl. 65: 16-21.
Aris RM, Guise TA 2005 Cystic fibrosis and bone disease: are we missing a genetic link? Eur. Respir. J. 25: 9-11. *
Armaka M, Apostolaki M, Jacques P, Kontoyiannis DL, Elewaut D, Kollias G 2008 Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases. J. Exp. Med. 205: 331-337. *
Artz E, Warren-Ulanch J, Becker D, Greenspan S, Freemark M 2008 Seropositivity to celiac antigens in asymptomatic children with type 1 diabetes mellitus: association with weight, height, and bone mineralization. Pediatr. Diabetes 9: 277-284.
Asagiri M, Hirai T, Kunigami T, Kamano S, Gober HJ, Okamoto K, Nishikawa K, Latz E, Golenbock DT, Aoki K, Ohya K, Imai Y, Morishita Y, Miyazono K, Kato S, Saftig P, Takayanagi H 2008 Cathepsin K-dependent Toll-like receptor 9 signaling revealed in experimental arthritis. Science 319: 624-627. *
Asquith DL, McInnes IB 2007 Emerging cytokine targets in rheumatoid arthritis. Curr. Opin. Rheumatol. 19: 246-251.
Atouf O, Benbouazza K, Brick C, Bzami F, Bennani N, Amine B, Hajja-Hassouni N, Essakali M 2008 HLA polymorphism and early rheumatoid arthritis in the Moroccan population. Joint Bone Spine Sep 16 [Epub ahead of print].
Aubourg P 2007 X-linked adrenoleukodystrophy. Ann. Endocrinol. (Paris) 68: 403-411.
Augello A, Tasso R, Negrini SM, Amateis A, Indiveri F, Cancedda R, Pennesi G 2005 Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur. J. Immunol. 35: 1482-1490. *
Augello A, Tasso R, Negrini SM, Cancedda R, Pennesi G 2007 Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum. 56: 1175-1186. *
Aurich I, Mueller LP, Aurich H, Luetzkendorf J, Tisljar K, Dollinger M, Schormann W, Walldorf J, Hengstler J, Fleig WE, Christ B 2007 Functional integration of human mesenchymal stem cell-derived hepatocytes into mouse livers. Gut 56: 405-415. *
Ayala-Garcia I, Hernandez-Segura AM, Castell-Rodriguez A, Alvarez Perez SJ, Tellez BH, Ramirez-Gonzalez MD 2005 Participation of epidermal Langerhans cells in human pathology and their potential as targets for drug development: a review of literature. Proc. West. Pharmacol. Soc. 48: 13-20.
Azarian M, Busson M, Rocha V, Ribaud P, Peffault de Latour R, Bleux H, Lepage V, Charron D, Toubert A, Socie G, Loiseau P 2008 The PTPN22 R620W polymorphism is associated with severe bacterial infections after human leukocyte antigen geno-identical haematopoietic stem-cell transplantations. Transplantation 85: 1859-1862.
Azarpira N, Ramzi M, Aghdaie MH, Darai M, Geramizadeh B 2008 Interleukin-10 gene polymorphism in bone marrow transplant recipients. Exp. Clin. Transplant. 6: 74-79.
Badillo AT, Beggs KJ, Javazon EH, Tebbets JC, Flake AW 2007 Murine bone marrow stromal progenitor cells elicit an in vivo cellular and humoral alloimmune response. Biol. Blood Marrow Transplant. 13: 412-422.
Badsha H, Kong KO, Tak PP 2008 Rheumatoid arthritis in the United Arab Emirates. Clin. Rheumatol. 27: 739-472. *
Baeke F, Etten EV, Gysemans C, Overbergh L, Mathieu C 2008 Vitamin D signaling in immune-mediated disorders: evolving insights and therapeutic opportunities. Mol. Aspects Med. Jul 12 [Epub ahead of print].
Baert F, Noman M, Vermeire S, Van Assche G, D' Haens G, Carbonez A, Rutgeerts P 2003 Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N. Engl. J. Med. 348: 601-608. *
Bagur A, Mautalen C, Findor J, Sorda J, Somoza J 1998 Risk factors for the development of vertebral and total skeleton osteoporosis in patients with primary biliary cirrhosis. Calcif. Tissue Int. 63: 385-390. *
Baharav E, Mor F, Halpern M, Quintana F, Weinberger A 2007 Tropomyosin-induced arthritis in rats. Clin. Exp. Rheumatol. 25: S86-S92.
Bai D, Brar P, Holleran S, Ramakrishnan R, Green P 2005 Effect of gender on the manifestations of celiac disease: evidence for greater malabsorption in men. Scand. J. Gastroenterol. 40: 183-187. *
Bailen LS 2001 Bones and Crohn's: should we treat Crohn's disease patients with alendronate? Inflamm. Bowel Dis. 7: 175-176. *
Baines M 1980 Clinical usefulness of the simultaneous localisation of the isoenzymes of alkaline phosphate and gamma-glutamyl transferase. Ann. Clin. Biochem. 17: 20-25.
Baioni CS, de Souza CM, Ribeiro Braosi AP, Luczyszyn SM, Dias da Silva MA, Ignacio SA, Naval Machado MA, Benato Martins WD, Riella MC, Pecoits-Filho R, Trevilatto PC 2008 Analysis of the association of polymorphism in the osteoprotegerin gene with susceptibility to chronic kidney disease and periodontitis. J. Periodontal Res. Jun 19 [Epub ahead of print].
Balaci L, Spada MC, Olla N, Sole G, Loddo L, Anedda F, Naitza S, Zuncheddu MA, Maschio A, Altea D, Uda M, Pilia S, Sanna S, Masala M, Crisponi L, Fattori M, Devoto M, Doratiotto S, Rassu S, Mereu S, Giua E, Cadeddu NG, Atzeni R, Pelosi U, Corrias A, et al 2007 IRAK-M is involved in the pathogenesis of early-onset persistent asthma. Am. J. Hum. Genet. 80: 1103-1114. *
Baldassarre ME, Altomare MA, Fanelli M, Carbone D, Di Bitonto G, Mautone A, Laforgia N 2007 Does calprotectin represent a regulatory factor in host defense or a drug target in inflammatory disease? Endocr. Metab. Immune Disord. Drug Targets 7: 1-5.
Baldini V, Casella G, Perego D, Morcelli E, Fraterrigo RT 2000 Hypocalcemic tetany due to coeliac disease. May this symptoms disappear? Minerva Gastroenterol. Dietol. 46: 99-104.
Balistreri WF 1997 Bile acid therapy in pediatric hepatobiliary disease: the role of ursodeoxycholic acid. J. Pediatr. Gastroenterol. Nutr. 24: 573-589.
Balotescu C, Israil A, Radu R, Alexandru I, Dobre G 2003 Aspects of constitutive and acquired antibioresistance in Aeromonas hydrophila strains isolated from water sources. Roum. Arch. Microbiol. Immunol. 62: 179-189.
Bamba S, Lee CY, Brittan M, Preston S, Direkze N, Poulsom R, Alison M, Wright N, Otto W 2006 Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice. J. Pathol. 209: 265-273. *
Ban Y, Ban Y, Taniyama M, Katagiri T 2000 Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease. Thyroid 10: 475-480.
Ban Y, Ban Y, Taniyama M, Katagiri T 2000 Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease. Thyroid 10: 375-380.
Ban Y, Concepcion ES, Villanueva R, Greenberg DA, Davies TF, Tomer Y 2004 Analysis of immune regulatory genes in familial and sporadic Graves' disease. J. Clin. Endocrinol. Metab. 89: 4562-4568. *
Ban Y, Davies TF, Greenberg DA, Concepcion ES, Osman R, Oashi T, Tomer Y 2004 Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease. Genes Immun. 5: 203-208. *
Ban Y, Davies TF, Greenberg DA, Kissin A, Marder B, Murphy B, Concepcion ES, Villanueva RB, Barbesino G, Ling V, Tomer Y 2003 Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun. 4: 586-593. *
Ban Y, Greenberg DA, Concepcion E, Skrabanek L, Villanueva R, Tomer Y 2003 Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc. Natl. Acad. Sci. U.S.A. 100: 15119-15124. *
Ban Y, Greenberg DA, Concepcion ES, Tomer Y 2002 A germline single nucleotide polymorphism at the intracellular domain of the human thyrotropin receptor does not have a major effect on the development of Graves' disease. Thyroid 12: 1079-1083.
Ban Y, Tomer Y 2003 The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases. Autoimmunity 36: 367-379.
Ban Y, Tomer Y 2005 Susceptibility genes in thyroid autoimmunity. Clin. Dev. Immunol. 12: 47-58. *
Ban Y, Tomer Y 2005 Genetic susceptibility in thyroid autoimmunity. Pediatr. Endocrinol. Rev. 3: 20-32.
Bannwarth B 2007 Drug-induced musculoskeletal disorders. Drug Saf. 30: 27-46.
Bao J, Wang Q, Zheng L, Qiu YR, Zeng FY, Yang CL, Huang XZ 2008 RelB silencing in mouse bone-marrow derived dendritic cells mediated by lentiviral vector. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 24: 857-860.
Bar-Shavit Z 2008 Taking a Toll on the bones: regulation of bone metabolism by innate immune regulators. Autoimmunity 41: 195-203.
Baraf HS 2007 Efficacy of the newest COX-2 selective inhibitors in rheumatic disease. Curr. Pharm. Des. 13: 2228-2236.
Barao I, Hanash AM, Hallett W, Welniak LA, Sun K, Redelman D, Blazar BR, Levy RB, Murphy WJ 2006 Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells. Proc. Natl. Acad. Sci. U.S.A. 103: 5460-5465. *
Bardella MT, Bianchi ML,Teti A 2005 Chronic inflammatory intestinal diseases and bone loss. Gut 54: 1508. *
Bargou R, Leo E, Zugmaier G, Klinger M, Goebeler M, Knop S, Noppeney R, Viardot A, Hess G, Schuler M, Einsele H, Brandl C, Wolf A, Kirchinger P, Klappers P, Schmidt M, Riethmuller G, Reinhardt C, Baeuerle PA, Kufer P 2008 Tumor regression in cancer patients by very low doses of a T cell-engaging antibody. Science 321: 974-977. *
Barnes DS 2002 Intrahepatic cholestatic liver disease. http://www.clevelandclinicmeded.com/diseasemanagement/gastro/intrahepatic/intrahepatic1.htm.
Baron F, Gothot A 2007 Mesenchymal stem cells: a new versatile therapeutic option. Rev. Med. Liege. 62 Spec. No.: 9-14.
Baron FA, Hermanne JP, Dowlati A, Weber T, Thiry A, Fassotte MF, Fillet G, Beguin Y 1998 Bronchiolitis obliterans organizing pneumonia and ulcerative colitis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 21: 951-954.
Barshes NR, Myers GD, Lee D, Karpen SJ, Lee TC, Patel AJ, Finegold M, Goss JA 2005 Liver transplantation for severe hepatic graft-versus-host disease: an analysis of aggregate survival data. Liver Transpl. 11: 525-531. *
Barton NJ, Stevens DA, Hughes JP, Rossi AG, Chessell IP, Reeve AJ, McQueen DS 2007 Demonstration of a novel technique to quantitatively assess inflammatory mediators and cells in rat knee joints. J. Inflamm. (Lond.) 4: 13.
Bartram SA, Peaston RT, Rawlings DJ, Francis RM, Thompson NP 2003 A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease. Aliment. Pharmacol. Ther. 18: 1121-1127. *
Bartram SA, Peaston RT, Rawlings DJ, Walshaw D, Francis RM, Thompson NP 2006 Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease. World J. Gastroenterol. 12: 5680-5686. *
Bartynski WS 2008 Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am. J. Neuroradiol. 29: 1036-1042.
Bayat A, Watson JS, Stanley JK, Alansari A, Shah M, Ferguson MW, Ollier WE 2002 Genetic susceptibility in Dupuytren's disease. TGF-beta1 polymorphisms and Dupuytren's disease. J. Bone Joint Surg. Br. 84: 211-215.
Beauchesne PR, Chung NS, Wasan KM 2007 Cyclosporine A: a review of current oral and intravenous delivery systems. Drug Dev. Ind. Pharm. 33: 211-220. *
Beck PL, Li Y, Wong J, Chen CW, Keenan CM, Sharkey KA, McCafferty DM 2007 Inducible nitric oxide synthase from bone marrow-derived cells plays a critical role in regulating colonic inflammation. Gastroenterology 132: 1778-1790. *
Becker A, Fischer R, Schneider M 2001 Bone density and 25-OH vitamin D serum level in patients with systemic lupus erythematosus. Z. Rheumatol. 60: 352-358.
Bell SA, Faust H, Schmid A, Meurer M 1998 Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases. Clin. Exp. Immunol. 113: 327-332. *
Belle SH, Beringer KC, Detre KM 1995 An update on liver transplantation in the United States: recipient characteristics and outcome. Clin. Transpl. 1995: 19-33.
Beltran E, Toll A, Pros A, Carbonell J, Pujol RM 2007 Assessment of nailfold capillaroscopy by x 30 digital epiluminescence (dermoscopy) in patients with Raynaud phenomenon. Br. J. Dermatol. 156: 892-898. *
Benchimol EI, Ward LM, Gallagher J, Rauch F, Barrowman N, Warren J, Beedle S, Mack DR 2007 Effect of calcium and vitamin D supplementation on bone mineral density in children with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 45: 538-545.
Bender IB 2003 Paget's disease. J. Endod. 29: 720-723.
Benetti A, Crosignani A, Varenna M, Giussani CS, Allocca M, Zuin M, Podda M, Battezzati PM 2008 Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study. J. Clin. Gastroenterol. 42: 306-311.
Bengoa JM, Sitrin MD, Meredith S, Kelly SE, Shah N, Baker AL, Rosenberg IH 1984 Intestinal calcium absorption and vitamin D status in chronic cholestatic liver disease. Hepatology 4: 261-265.
Berdowska I 2004 Cysteine proteases as disease markers. Clin. Chim. Acta 342: 41-69. *
Berentsen S, Ulvestad E, Langholm R, Beiske K, Hjorth-Hansen H, Ghanima W, Sorbo JH, Tjonnfjord GE 2006 Primary chronic cold agglutinin disease: a population based clinical study of 86 patients. Haematologica 91: 460-466. *
Bergasa NV 2003 Management of complications of cholestasis: pruritus, fatigue and bone disease. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper�s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 54. October 15-16. *
Bergasa NV, Mason A, Floreani A, Heathcote J, Swain MG, Jones DE, Lindor KM, Bassendine MF, Worman HJ 2004 Primary biliary cirrhosis: report of a focus study group. Hepatology 40: 1013-1020. *
Bergseng E, Xia J, Kim CY, Khosla C, Sollid LM 2005 Main chain hydrogen bond interactions in the binding of proline-rich gluten peptides to the celiac disease associated HLA-DQ2 molecule. J. Biol. Chem. 280: 21791-21796. *
Bergtold A, Gavhane A, D'Agati V, Madaio M, Clynes R 2006 FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis. J. Immunol. 177: 7287-7295. *
Berlo SE, Guichelaar T, Ten Brink CB, van Kooten PJ, Hauet-Broeren F, Ludanyi K, van Eden W, Broeren CP, Glant TT 2006 Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice. Arthritis Rheum. 54: 2423-2433. *
Berlo SE, van Kooten PJ, Ten Brink CB, Hauet-Broere F, Oosterwegel MA, Glant TT, Van Eden W, Broeren CP 2005 Naive transgenic T cells expressing cartilage proteoglycan-specific TCR induce arthritis upon in vivo activation. J. Autoimmun. 25: 172-180.
Bernhardt WM, Schefold JC, Weichert W, Rudolph B, Frei U, Groneberg DA, Schindler R 2006 Amelioration of anemia after kidney transplantation in severe secondary oxalosis. Clin. Nephrol. 65: 216-221.
Bernstein CN 2002 Treatment of the extraintestinal manifestations of inflammatory bowel disease. Curr. Gastroenterol. Rep. 4: 513-516.
Bernstein CN, Bector S, Leslie WD 2003 Lack of relationship of calcium and vitamin D intake to bone mineral density in premenopausal women with inflammatory bowel disease. Am. J. Gastroenterol. 98: 2468-2473. *
Bernstein CN, Leslie WD 2005 Therapy insight: osteoporosis in inflammatory bowel disease - advances and retreats. Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 232-239. *
Bernstein CN, Leslie WD 2003 The pathophysiology of bone disease in gastrointestinal disease. Eur. J. Gastroenterol. Hepatol. 15: 857-864.
Bernstein CN, Leslie WD 2004 Osteoporosis and inflammatory bowel disease. Aliment. Pharmacol. Ther. 19: 941-952. *
Bernstein CN, Sargent M, Leslie WD 2005 Serum osteoprotegerin is increased in Crohn's disease: a population-based case control study. Inflamm. Bowel Dis. 11: 325-330. *
Bernstein CN, Seeger LL, Anton PA, Artinian L, Geffrey S, Goodman W, Belin TR, Shanahan F 1996 A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study. Aliment. Pharmacol. Ther. 10: 777-786.
Bernstein M, Irwin S, Greenberg GR 2005 Maintenance infliximab treatment is associated with improved bone mineral density in Crohn's disease. Am. J. Gastroenterol. 100: 2031-2035. *
Besler C, Doerries C, Giannotti G, Luscher TF, Landmesse U 2008 Pharmacological approaches to improve endothelial repair mechanisms. Expert Rev. Cardiovasc. Ther. 6: 1071-1082.
Bettendorf M, Doerr HG, Hauffa BP, Lindberg A, Mehls O, Partsch CJ, Schwarz HP, Stahnke N, Ranke MB 2006 Prevalence of autoantibodies associated with thyroid and celiac disease in Ullrich-Turner syndrome in relation to adult height after growth hormone treatment. J. Pediatr. Endocrinol. Metab. 19: 149-154.
Bhadada SK, Udawat HP, Bhansali A, Rana SS, Sinha SK, Bhasin DK 2008 Chronic pancreatitis in primary hyperparathyroidism: comparison with alcoholic and idiopathic chronic pancreatitis. J. Gastroenterol. Hepatol. 23: 959-964. *
Bi L, Triadafilopoulos G 2003 Exercise and gastrointestinal function and disease: an evidence-based review of risks and benefits. Clin. Gastroenterol. Hepatol. 1: 345-355. *
Bianchi ML 2005 How to manage osteoporosis in children. Best Pract. Res. Clin. Rheumatol. 19: 991-1005.
Bianchi ML, Bardella MT 2008 Bone in celiac disease. Osteoporos Int. Apr 17 [Epub ahead of print].
Biancone L, Schillaci O, Capoccetti F, Bozzi RM, Fina D, Petruzziello C, Geremia A, Simonetti G, Pallone F 2005 Technetium-99m-HMPAO labeled leukocyte single photon emission computerized tomography (SPECT) for assessing Crohn's disease extent and intestinal infiltration. Am. J. Gastroenterol. 100: 344-354. *
Bird TG, Lorenzini S, Forbes SJ 2008 Activation of stem cells in hepatic diseases. Cell Tissue Res. 331: 283-300. *
Bitan M, Weiss L, Zeira M, Reich S, Pappo O, Vlodavsky I, Slavin S 2008 Heparanase prevents the development of type 1 diabetes in non-obese diabetic mice by regulating T-cell activation and cytokines production. Diabetes Metab. Res. Rev. 24: 413-421.
Bjarnason I, Macpherson A, Mackintosh C, Buxton-Thomas M, Forgacs I, Moniz C 1997 Reduced bone density in patients with inflammatory bowel disease. Gut 40: 228-233. *
Bjornsson E, Chapman RW 2003 Sclerosing cholangitis. Curr. Opin. Gastroenterol. 19: 270-275.
Bjursten M, Willen R, Hultgren Hornquist E 2005 Transfer of colitis by Galphai2-deficient T lymphocytes: impact of subpopulations and tissue origin. Inflamm. Bowel Dis. 11: 997-1005. *
Blair HC, Carrington JL 2006 Bone cell precursors and the pathophysiology of bone loss. Ann. N. Y. Acad. Sci. 1068: 244-249.
Blanchet E, Beau P, Frat JP 2004 Bone marrow aplasia following dipyrone treatment in a patient with Crohn's disease receiving long-term methotrexate. Gastroenterol. Clin. Biol. 28: 502-503.
Bluestone JA 2007 A balanced attack. The Scientist May, 2007 (http://www.the-scientist.com/2007/05/01/s32/1/ ).
Bobacz K, Sunk IG, Hofstaetter JG, Amoyo L, Toma CD, Akira S, Weichhart T, Saemann M, Smolen JS 2007 Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of Toll-like receptor 4 and antagonized by bone morphogenetic protein 7. Arthritis Rheum. 56: 1880-1893. *
Bocelli-Tyndall C, Bracci L, Schaeren S, Feder-Mengus C, Barbero A, Tyndall A, Spagnoli GC 2008 Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated with the cytokines IL 2, IL 7 and IL 15. Ann. Rheum. Dis. Jul 22 [Epub ahead of print].
Bocelli-Tyndall C, Bracci L, Spagnoli G, Braccini A, Bouchenaki M, Ceredig R, Pistoia V, Martin I, Tyndall A 2007 Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro. Rheumatology (Oxford) 46: 403-408. *
Bodini A, D Orazio C, Peroni DG, Corradi M, Zerman L, Folesani G, Assael BM, Boner AL, Piacentini GL 2007 IL-8 and pH values in exhaled condensate after antibiotics in cystic fibrosis children. Int. J. Immunopathol. Pharmacol. 20: 467-472.
Bogoyevitch MA 2006 The isoform-specific functions of the c-Jun N-terminal kinases (JNKs): differences revealed by gene targeting. Bioessays 28: 923-934. *
Bohn G, Hardtke-Wolenski M, Zeidler C, Maecker B, Sauer M, Sykora KW, Grigull L, Welte K, Klein C 2008 Lethal graft-versus-host disease in congenital neutropenia caused by p14 deficiency after allogeneic bone marrow transplantation from an HLA-identical sibling. Pediatr. Blood Cancer 51: 436-438.
Boldt AB, Luty A, Grobusch MP, Dietz K, Dzeing A, Kombila M, Kremsner PG, Kun JF 2006 Association of a new mannose-binding lectin variant with severe malaria in Gabonese children. Genes Immun. 7: 393-400. *
Bolt MJ, Sitrin MD, Favus MJ, Rosenberg IH 1981 Hepatic vitamin D 25-hydroxylase: inhibition by bile duct ligation or bile salts. Hepatology 1: 436-440.
Bona D, Incarbone R, Chella B, Vecchi M, Bonavina L 2005 Heartburn and multiple-site foregut perforations as primary manifestation of Crohn's disease. Dis. Esophagus 18: 199-201. *
Bonelli M, Savitskaya A, von Dalwigk K, Steiner CW, Aletaha D, Smolen JS, Scheinecker C 2008 Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int. Immunol. 20: 861-868.
Bonen DK, Cho JH 2003 The genetics of inflammatory bowel disease. Gastroenterology 124: 521-536. *
Bonen DK, Ogura Y, Nicolae DL, Inohara N, Saab L, Tanabe T, Chen FF, Foster SJ, Duerr RH, Brant SR, Cho JH, Nunez G 2003 Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 124: 140-146. *
Boner AL, Peroni D, Bodini A, Delaini G, Piacentini G 2007 Azithromycin may reduce cholestasis in primary sclerosing cholangitis: a case report and serendipitous observation. Int. J. Immunopathol. Pharmacol. 20: 847-849.
Bongi SM, Porfirio B, Rombola G, Palasciano A, Beneforti E, Bianucci G 2004 Shared-epitope HLA-DRB1 alleles and sex ratio in Italian patients with rheumatoid arthritis. Joint Bone Spine. 71: 24-28.
Bonkovsky HL, Hawkins M, Steinberg K, Hersh T, Galambos JT, Henderson JM, Millikan WJ, Galloway JR 1990 Prevalence and prediction of osteopenia in chronic liver disease. Hepatology 12: 273-280.
Borba VZ, Vieira JG, Kasamatsu T, Radominski SC, Sato EI, Lazaretti-Castro M 2008 Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos. Int. Jul 4 [Epub ahead of print].
Borgiani P, Vallo L, D'Apice MR, Giardina E, Pucci S, Capon F, Nistico S, Chimenti S, Pallone F, Novelli G 2002 Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population. Eur. J. Dermatol. 12: 540-542.
Borman P, Babaoglu S, Gur G, Bingol S, Bodur H 2008 Bone mineral density and bone turnover in patients with psoriatic arthritis. Clin. Rheumatol. 27: 443-447. *
Boubaker J, Feki M, Hsairi M, Fekih M, Kaabachi N, Filali A, Mebazaa A 2003 Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients. Gastroenterol. Clin. Biol. 27: 901-907.
Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M 2008 Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. Aug 11 [Epub ahead of print]. *
Boulton-Jones JR, Fenn RM, West J, Logan RF, Ryder SD 2004 Fracture risk of women with primary biliary cirrhosis: no increase compared with general population controls. Aliment. Pharmacol. Ther. 20: 551-557. *
Bourges O, Dorgeret S, Alberti C, Hugot JP, Sebag G, Cezard JP 2004 Low bone mineral density in children with Crohn's disease. Arch. Pediatr. 11: 800-806.
Bouysset M, Noel E, Tebib JG 2005 Rheumatoid arthritis: a general disease and local diseases. Rev. Prat. 55: 2121-2133.
Bouzaidi S, Ben Salem M, Mnif N, Ben Hammouda I, Ben Yedder J, Trabelsi S, Moussa A, Jemaa Y, Debbech R, Salem M, Najjar T, Hamza R 2004 Bone mineral density in patients with Crohn's disease: about 53 cases. Tunis. Med. 82: 753-759.
Bowden SA, Robinson RF, Carr R, Mahan JD 2008 Prevalence of vitamin D deficiency and insufficiency in children with osteopenia or osteoporosis referred to a pediatric metabolic bone clinic. Pediatrics 121: e1585-e1590. *
Boyce BF, Li P, Yao Z, Zhang Q, Badell IR, Schwarz EM, O'keefe RJ, Xing L 2005 TNFa and pathologic bone resorption. Keio. J. Med. 54: 127-131. *
Boyce BF, Schwarz EM, Xing L 2006 Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease. Curr. Opin. Rheumatol. 18: 427-432.
Boyle K, Egan P, Rakar S, Willson TA, Wicks IP, Metcalf D, Hilton DJ, Nicola NA, Alexander WS, Roberts AW, Robb L 2007 The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo. Blood 110: 1466-1474. *
Braier J, Chantada G, Rosso D, Bernaldez P, Amaral D, Latella A, Balancini B, Masautis A, Goldberg J 1999 Langerhans cell histiocytosis: retrospective evaluation of 123 patients at a single institution. Pediatr. Hematol. Oncol. 16: 377-385.
Braier J, Ciocca M, Latella A, de Davila MG, Drajer M, Imventarza O 2002 Cholestasis, sclerosing cholangitis, and liver transplantation in Langerhans cell histiocytosis. Med. Pediatr. Oncol. 38: 178-182. *
Brancaccio D, Bommer J, Coyne D 2007 Vitamin D receptor activator selectivity in the treatment of secondary hyperparathyroidism: understanding the differences among therapies. Drugs 67: 1981-1998.
Brandt DJ, MacCarty RL, Charboneau JW, LaRusso NF, Wiesner RH, Ludwig J 1988 Gallbladder disease in patients with primary sclerosing cholangitis. AJR Am. J. Roentgenol. 150: 571-574. *
Brannon PM, Yetley EA, Bailey RL, Picciano MF 2008 Summary of roundtable discussion on vitamin D research needs. Am. J. Clin. Nutr. 88: 587S-592S. *
Brant SR, Panhuysen CI, Nicolae D, Reddy DM, Bonen DK, Karaliukas R, Zhang L, Swanson E, Datta LW, Moran T, Ravenhill G, Duerr RH, Achkar JP, Karban AS, Cho JH 2003 MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am. J. Hum. Genet.73: 1282-1292. *
Brant SR, Picco MF, Achkar JP, Bayless TM, Kane SV, Brzezinski A, Nouvet FJ, Bonen D, Karban A, Dassopoulos T, Karaliukas R, Beaty TH, Hanauer SB, Duerr RH, Cho JH 2003 Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm. Bowel Dis. 9: 281-289. *
Braun F, Behrend M 2006 Basic immunosuppressive drugs outside solid organ transplantation. Expert Opin. Investig. Drugs 15: 267-291.
Breban M, Miceli-Richard C, Zinovieva E, Monnet D, Said-Nahal R 2006 The genetics of spondyloarthropathies. Joint Bone Spine 73: 355-362.
Bregenzer N, Schaffler A, Gelbmann CM, Steinkamp M, Reinshagen M, Scholmerich J, Andus T 2006 Lack of correlation between the vitamin D receptor Fokl start codon polymorphism and bone mineral density in patients with Crohn's disease. Exp. Clin. Endocrinol. Diabetes 114: 1-5.
Brenner M, Laragione T, Mello A, Gulko PS 2007 Cia25 on rat chromosome 12 regulates severity of autoimmune arthritis induced with pristane and collagen. Ann. Rheum. Dis. 66: 952-957. *
Brenner M, Laragione T, Yarlett NC, Li W, Mello A, Gulko PS 2006 Cia27 is a novel non-MHC arthritis severity locus on rat chromosome 10 syntenic to the rheumatoid arthritis 17q22-q25 locus. Genes Immun. 7: 335-341. *
Brenner M, Meng HC, Yarlett NC, Griffiths MM, Remmers EF, Wilder RL, Gulko PS 2005 The non-major histocompatibility complex quantitative trait locus Cia10 contains a major arthritis gene and regulates disease severity, pannus formation, and joint damage. Arthritis Rheum. 52: 322-332. *
Bret J, Lemaire O, Prat C, Zabraniecki L, Fournie B 2008 Aseptic osteomyelitis responding to TNFalpha antagonist therapy in a patient with Crohn's disease. Joint Bone Spine 75: 489-491.
Brett PJ, Burtnick MN, Snyder DS, Shannon JG, Azadi P, Gherardini FC 2007 Burkholderia mallei expresses a unique lipopolysaccharide mixture that is a potent activator of human Toll-like receptor 4 complexes. Mol. Microbiol. 63: 379-390. *
Briani C, Samaroo D, Alaedini A 2008 Celiac disease: from gluten to autoimmunity. Autoimmun. Rev. 7: 644-650.
Brinckerhoff CE, Sporn MB 2003 Retinoids and rexinoids for the 21st century: a brave new world for arthritis. J. Rheumatol. 30: 211-213.
Brinkman DM, Jol-van der Zijde CM, Ten Dam MM, Te Boekhorst PA, Ten Cate R, Wulffraat NM, Hintzen RQ, Vossen JM, van Tol MJ 2007 Resetting the adaptive immune system after autologous stem cell transplantation: lessons from responses to vaccines. J. Clin. Immunol. 27: 647-658. *
Briot K, Gossec L, Kolta S, Dougados M, Roux C 2008 Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment. J. Rheumatol. 35: 855-861.
Brittan M, Chance V, Elia G, Poulsom R, Alison MR, Macdonald TT, Wright NA 2005 A regenerative role for bone marrow following experimental colitis: contribution to neovasculogenesis and myofibroblasts. Gastroenterology 128: 1984-1995. *
Brocq O, Roux CH, Albert C, Breuil V, Aknouche N, Ruitord S, Mousnier A, Euller-Ziegler L 2007 TNFalpha antagonist continuation rates in 442 patients with inflammatory joint disease. Joint Bone Spine 74: 148-154.
Brodsky RA, Jones RJ 2005 Aplastic anaemia. Lancet 365: 1647-1656. *
Brooks PM 1997 Hematopoietic stem cell transplantation for autoimmune diseases. J. Rheumatol. Suppl. 48: 19-22.
Brooks PM 2006 The burden of musculoskeletal disease - a global perspective. Clin. Rheumatol. 25: 778-781. *
Brown AJ, Slatopolsky E 2008 Vitamin D analogs: therapeutic applications and mechanisms for selectivity. Mol. Aspects Med. May 1 [Epub ahead of print].
Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E, Wakefield RJ, O'connor PJ, Emery P 2006 Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum. 54: 3761-3773. *
Brown HJ, Lock HR, Sacks SH, Robson MG 2006 TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis. J. Immunol. 177: 1925-1931. *
Brown HJ, Lock HR, Wolfs TG, Buurman WA, Sacks SH, Robson MG 2007 Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2. J. Am. Soc. Nephrol. 18: 1732-1739.
Brown JM, Schwanke CM, Pershouse MA, Pfau JC, Holian A 2005 Effects of rottlerin on silica-exacerbated systemic autoimmune disease in New Zealand mixed mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L990-L998. *
Bruhl H, Cihak J, Schneider MA, Plachy J, Rupp T, Wenzel I, Shakarami M, Milz S, Ellwart JW, Stangassinger M, Schlondorff D, Mack M 2004 Dual role of CCR2 during initiation and progression of collagen-induced arthritis: evidence for regulatory activity of CCR2+ T cells. J. Immunol. 172: 890-898. *
Bruscia EM, Ziegler EC, Price JE, Weiner S, Egan ME, Krause DS 2006 Engraftment of donor derived epithelial cells in multiple organs following bone marrow transplantation into newborn mice. Stem Cells 24: 2299-2308. *
Buchau AS, Gallo RL 2007 Innate immunity and antimicrobial defense systems in psoriasis. Clin. Dermatol. 25: 616-624.
Buchholz S, Dammann E, Koenecke C, Stadler M, Franzke A, Blasczyk R, Bremer M, Krauter J, Hertenstein B, Ganser A, Eder M 2008 Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults-a single-centre experience. Ann. Hematol. 87: 551-556. *
Buchman AL 2002 Metabolic bone disease in inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 5: 173-180.
Buchman AL 2007 Metabolic bone disease and inflammatory bowel disease. Am. J. Gastroenterol. 102 Suppl. 1: S49-S55. *
Buchman AL 1999 Bones and Crohn's: problems and solutions. Inflamm. Bowel Dis. 5: 212-227.
Bulian P, Gaidano G, Poeta GD, Gattei V 2008 CD49d expression in chronic lymphocytic leukemia: a prognostic parameter and a therapeutic target. Future Oncol. 4: 355-358.
Buning C, Schmidt HH, Molnar T, DE Jong DJ, Fiedler T, Buhner S, Sturm A, Baumgart DC, Nagy F, Lonovics J, Drenth JP, Landt O, Nickel R, Buttner J, Lochs H, Witt H 2007 Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis. Aliment. Pharmacol. Ther. 26: 1025-1033. *
Burnham JM, Shults J, Petit MA, Semeao E, Beck TJ, Zemel BS, Leonard MB 2007 Alterations in proximal femur geometry in children treated with glucocorticoids for Crohn disease or nephrotic syndrome: impact of the underlying disease. J. Bone Miner. Res. 22: 551-559.
Burnham JM, Shults J, Semeao E, Foster B, Zemel BS, Stallings VA, Leonard MB 2004 Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J. Bone Miner. Res. 19: 1961-1968.
Burrage PS, Mix KS, Brinckerhoff CE 2006 Matrix metalloproteinases: role in arthritis. Front. Biosci. 11: 529-543.
Burt RK, Loh Y, Pearce W, Beohar N, Barr WG, Craig R, Wen Y, Rapp JA, Kessler J 2008 Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 299: 925-936. *
Burt RK, Traynor AE, Cohen B, Karlin KH, Davis FA, Stefoski D, Terry C, Lobeck L, Russell EJ, Goolsby C, Rosen S, Gordon LI, Keever-Taylor C, Brush M, Fishman M, Burns WH 1998 T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients. Bone Marrow Transplant. 21: 537-541.
Burt RK, Traynor AE, Pope R, Schroeder J, Cohen B, Karlin KH, Lobeck L, Goolsby C, Rowlings P, Davis FA, Stefoski D, Terry C, Keever-Taylor C, Rosen S, Vesole D, Fishman M, Brush M, Mujias S, Villa M, Burns WH 1998 Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation. Blood 92: 3505-3514. *
Bush KA, Farmer KM, Walker JS, Kirkham BW 2002 Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein. Arthritis Rheum. 46: 802-805. *
Bustamante M, Nogues X, Mellibovsky L, Agueda L, Jurado S, Caceres E, Blanch J, Carreras R, Diez-Perez A, Grinberg D, Balcells S 2007 Polymorphisms in the interleukin-6 receptor gene are associated with bone mineral density and body mass index in Spanish postmenopausal women. Eur. J. Endocrinol. 157: 677-684. *
Byrne FR, Morony S, Warmington K, Geng Z, Brown HL, Flores SA, Fiorino M, Yin SL, Hill D, Porkess V, Duryea D, Pretorius JK, Adamu S, Manuokian R, Danilenko DM, Sarosi I, Lacey DL, Kostenuik PJ, Senaldi G 2005 CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin. Gut 54: 78-86. *
Cabre E, Gassull MA 2001 Nutrition in inflammatory bowel disease: impact on disease and therapy. Curr. Opin. Gastroenterol. 17: 342-349.
Cabre E, Gassull MA 2003 Nutritional and metabolic issues in inflammatory bowel disease. Curr. Opin. Clin. Nutr. Metab. Care 6: 569-576.
Cai X, Wong YF, Zhou H, Xie Y, Liu ZQ, Jiang ZH, Bian ZX, Xu HX, Liu L 2006 The comparative study of Sprague-Dawley and Lewis rats in adjuvant-induced arthritis. Naunyn. Schmiedebergs. Arch. Pharmacol. 373: 140-147. *
Caldeira RJ, Fonseca VD, Gomes Junior SC, de Miranda Chaves CR 2008 Prevalence of bone mineral disease among adolescents with cystic fibrosis. J. Pediatr. (Rio J.) 84: 18-25.
Camisasca M, Crosignani A, Battezzati PM, Albisetti W, Grandinetti G, Pietrogrande L, Biffi A, Zuin M, Podda M 1994 Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis. Hepatology 20: 633-637.
Campana C, Regazzi MB, Buggia I, Molinaro M 1996 Clinically significant drug interactions with cyclosporin. An update. Clin. Pharmacokinet. 30: 141-179.
Campbell MS, Lichtenstein GR, Rhim AD, Pazianas M, Faust T 2005 Severity of liver disease does not predict osteopenia or low bone mineral density in primary sclerosing cholangitis. Liver Int. 25: 311-316. *
Cansu D, Kasifoglu T, Pasaoglu O, Korkmaz C 2008 Autoerythrocyte sensitization syndrome (Gardner-Diamond syndrome) associated with cutaneous vasculitis. Joint Bone Spine Apr 14 [Epub ahead of print].
Cantorna MT, Mahon BD 2004 Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp. Biol. Med. (Maywood) 229: 1136-1142. *
Cantz T, Manns MP, Ott M 2008 Stem cells in liver regeneration and therapy. Cell Tissue Res. 331: 271-282. *
Cantz T, Sharma AD, Jochheim-Richter A, Arseniev L, Klein C, Manns MP, Ott M 2004 Reevaluation of bone marrow-derived cells as a source for hepatocyte regeneration. Cell Transplant. 13: 659-666.
Caplan AI 2007 Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell Physiol. 213: 341-347. *
Caramella C, Avouac J, Sogni P, Puechal X, Kahan A, Allanore Y 2007 Association between rheumatoid arthritis and primary biliary cirrhosis. Joint Bone Spine 74: 279-281.
Carbone E, Neri P, Mesuraca M, Fulciniti MT, Otsuki T, Pende D, Groh V, Spies T, Pollio G, Cosman D, Catalano L, Tassone P, Rotoli B, Venuta S 2005 HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells. Blood 105: 251-258. *
Carbone J 2007 Adverse reactions and pathogen safety of intravenous immunoglobulin. Curr. Drug Saf. 2: 9-18.
Carbone J, Escudero A, Mayayo M, Ballesteros M, Perez-Corral A, Sanchez-Ramon S, Sarmiento E, Micheloud D, Fernandez-Cruz E 2005 Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency. Ann. N. Y. Acad. Sci. 1051: 666-671.
Carbone J, Gonzalez-Lara V, Sarmiento E, Chean C, Perez JL, Marin I, Rodriguez-Molina JJ, Gil J, Fernandez-Cruz E 2007 Humoral and cellular monitoring to predict the development of infection in Crohn's disease patients beginning treatment with infliximab. Ann. N. Y. Acad. Sci. 1107: 346-355. *
Carbone J, Lanio N, Gallego A, Sarmiento E 2008 Immune monitoring to predict the development of infections after immunosuppression for solid organ transplantation and autoimmune diseases. Curr. Drug Saf. 3: 91-99.
Carbone J, Micheloud D, Salcedo M, Rincon D, Banares R, Clemente G, Jensen J, Sarmiento E, Rodriguez-Molina J, Fernandez-Cruz E 2008 Humoral and cellular immune monitoring might be useful to identify liver transplant recipients at risk for development of infection. Transpl. Infect. Dis. Jul 24 [Epub ahead of print].
Carbone J, Perez-Fernandez R, Munoz A, Sabin P, Carreno L, Fernandez-Cruz E 2008 Combined therapy with rituximab plus cyclophosphamide/vincristine/prednisone for Sjogren's syndrome-associated B-cell non-Hodgkin's lymphoma. Clin. Rev. Allergy Immunol. 34: 80-84. *
Carbone J, Sarmiento E, Micheloud D, Rodriguez-Mahou M, Rodriguez-Molina JJ, Cobo R, Fernandez-Cruz E 2006 Systemic autoimmune disease in patients with uveitis. Arch. Soc. Esp. Oftalmol. 81: 193-198.
Carbone J, Sarmiento E, Rodriguez-Molina J, Fernandez-Cruz E 2004 Atypical presentation of common variable immunodeficiency without infections. Allergol. Immunopathol. (Madr.) 32: 218-222.
Card T, West J, Hubbard R, Logan RF 2004 Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study. Gut 53: 251-255. *
Carl JW Jr, Liu JQ, Joshi PS, El-Omrani HY, Yin L, Zheng X, Whitacre CC, Liu Y, Bai XF 2008 Autoreactive T cells escape clonal deletion in the thymus by a CD24-dependent pathway. J. Immunol. 181: 320-328.
Carson KL, Hunt CM 1997 Medical problems occurring after orthotopic liver transplantation. Dig. Dis. Sci. 42: 1666-1674. *
Casali AM, Carbone G, Cavalli G 1998 Intrahepatic bile duct loss in primary sclerosing cholangitis: a quantitative study. Histopathology 32: 449-453.
Cashman KD 2008 Altered bone metabolism in inflammatory disease: role for nutrition. Proc. Nutr. Soc. 67: 196-205. *
Caspi O, Polliack A, Klar R, Ben-Yehuda D 1995 The association of inflammatory bowel disease and leukemia - coincidence or not? Leuk. Lymphoma 17: 255-262.
Cassinotti A, Annaloro C, Ardizzone S, Onida F, Volpe AD, Clerici M, Usardi P, Greco S, Maconi G, Porro GB, Deliliers GL 2008 Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease. Gut 57: 211-217.
Cauley JA 2006 Osteoporosis in men: prevalence and investigation. Clin. Cornerstone 8 Suppl. 3: S20-S25.
Cavazzana I, Ceribelli A, Franceschini F, Cattaneo R 2007 Unusual association between pure red cell aplasia and primary Sjogren's syndrome: a case report. Clin. Exp. Rheumatol. 25: 309-311.
Caversaccio M, Bonel HM, Carter R, Williams AP, Gadola SD 2008 TAP deficiency syndrome: chronic rhinosinusitis and conductive hearing loss. Eur. Arch. Otorhinolaryngol. 265: 1289-1292.
Cawston TE, Wilson AJ 2006 Understanding the role of tissue degrading enzymes and their inhibitors in development and disease. Best Pract. Res. Clin. Rheumatol. 20: 983-1002.
Cha SH, Lee WK, Kwak JO, Hwang JS, Suh CK 2008 Identification and characterization of single nucleotide polymorphisms of SLC22A11 (hOAT4) in Korean women osteoporosis patients. Mol. Cells 25: 265-271.
Chabas D 2005 Osteopontin, a multi-faceted molecule. Med. Sci. (Paris) 21: 832-838.
Chan BY, Gartland A, Wilson PJ, Buckley KA, Dillon JP, Fraser WD, Gallagher JA 2007 PPAR agonists modulate human osteoclast formation and activity in vitro. Bone 40: 149-159. *
Chan J, Clements W, Field J, Nasa Z, Lock P, Yap F, Toh BH, Alderuccio F 2006 Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice. J. Gene Med. 8: 1281-1290.
Chang SK, Arendt BK, Darce JR, Wu X, Jelinek DF 2006 A role for BLyS in the activation of innate immune cells. Blood 108: 2687-2694. *
Chang X, Zheng P, Liu Y 2006 FoxP3: a genetic link between immunodeficiency and autoimmune diseases. Autoimmun. Rev. 5: 399-402.
Chao SC, Yang CC, Lee JY 2005 Hypersensitivity syndrome and pure red cell aplasia following allopurinol therapy in a patient with chronic kidney disease. Ann. Pharmacother. 39: 1552-1556.
Chapman RW 2003 The management of primary sclerosing cholangitis. Curr. Gastroenterol. Rep. 5: 9-17.
Chatfield SM, Brand C, Ebeling PR, Russell DM 2007 Vitamin D deficiency in general medical inpatients in summer and winter. Intern. Med. J. 37: 377-382. *
Chauveau C, Remy S, Royer PJ, Hill M, Tanguy-Royer S, Hubert FX, Tesson L, Brion R, Beriou G, Gregoire M, Josien R, Cuturi MC, Anegon I 2005 Heme oxygenase-1 expression inhibits dendritic cell maturation and pro-inflammatory function but conserves IL-10 expression. Blood 106: 1694-1702. *
Chen C, Li H, Tian Q, Beardall M, Xu Y, Casanova N, Weigert M 2006 Selection of anti-double-stranded DNA B cells in autoimmune MRL-lpr/lpr mice. J. Immunol. 176: 5183-5190. *
Chen HL, Wang R, Chen HL, Hwu WL, Jeng YM, Chang MH, Ling V 2008 Bone marrow transplantation results in donor-derived hepatocytes in an animal model of inherited cholestatic liver disease. J. Biomed. Sci. May 29 [Epub ahead of print]. *
Chen X, Handgretinger R, Hale GA 2008 Molecular monitoring of immune reconstitution after haploidentical stem cell transplantation. Curr. Stem Cell Res. Ther. 3: 75-78.
Chen X, Vodanovic-Jankovic S, Johnson B, Keller M, Komorowski R, Drobyski WR 2007 Absence of regulatory T cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft versus host disease. Blood 110: 3804-3813. *
Chen Y, Donnelly E, Kobayashi H, Debusk LM, Lin PC 2005 Gene therapy targeting the Tie2 function ameliorates collagen-induced arthritis and protects against bone destruction. Arthritis Rheum. 52: 1585-1594. *
Chen Y, Perry D, Boackle SA, Sobel ES, Molina H, Croker BP, Morel L 2005 Several genes contribute to the production of autoreactive B and T cells in the murine lupus susceptibility locus Sle1c. J. Immunol. 175: 1080-1089. *
Cheng JB, Motola DL, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW 2004 Identification and characterization of CYP2R1, a microsomal vitamin D 25-hydroxylase. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 21. June 18-19. *
Cheng S, Coyne D 2007 Vitamin D and outcomes in chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 16: 77-82.
Chernajovsky Y, Dreja H, Daly G, Annenkov A, Gould D, Adams G, Croxford JL, Baker D, Podhajcer OL, Mageed RA 2000 Immuno- and genetic therapy in autoimmune diseases. Genes Immun. 1: 295-307. *
Chernajovsky Y, Gould DJ, Podhajcer OL 2004 Gene therapy for autoimmune diseases: quo vadis? Nat. Rev. Immunol. 4: 800-811. *
Cherry K 2006 Measuring bone mineral density in celiac disease patients. Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 6. *
Chikanza IC, Kozaci D, Chernajovsky Y 2003 The molecular and cellular basis of corticosteroid resistance. J. Endocrinol. 179: 301-310. *
Chikuma S, Bluestone JA 2007 Expression of CTLA-4 and FOXP3 in cis protects from lethal lymphoproliferative disease. Eur. J. Immunol. 37: 1285-1289. *
Cho J 2000 Update on inflammatory bowel disease genetics. Curr. Gastroenterol. Rep. 2: 434-439.
Cho JH, Nicolae DL, Ramos R, Fields CT, Rabenau K, Corradino S, Brant SR, Espinosa R, LeBeau M, Hanauer SB, Bodzin J, Bonen DK 2000 Linkage and linkage disequilibrium in chromosome band 1p36 in American Chaldeans with inflammatory bowel disease. Hum. Mol. Genet. 9: 1425-1432. *
Christakos S, Dhawan P, Shen Q, Peng X, Benn B, Zhong Y 2006 New insights into the mechanisms involved in the pleiotropic actions of 1,25dihydroxyvitamin D3. Ann. N. Y. Acad. Sci. 1068: 194-203.
Chu VT, Enghard P, Riemekasten G, Berek C 2007 In vitro and in vivo activation induces BAFF and APRIL expression in B cells. J. Immunol. 179: 5947-5957.
Churchman SM, Ponchel F 2008 Interleukin-7 in rheumatoid arthritis. Rheumatology (Oxford) 47: 753-759.
Ciacci C, Spagnuolo G, Tortora R, Bucci C, Franzese D, Zingone F, Cirillo M 2008 Urinary stone disease in adults with celiac disease: prevalence, incidence and urinary determinants. J. Urol. 180: 974-979.
Ciccocioppo R, Ricci G, Rovati B, Pesce I, Mazzocchi S, Piancatelli D, Cagnoni A, Millimaggi D, Danova M, Corazza GR 2007 Reduced number and function of peripheral dendritic cells in coeliac disease. Clin. Exp. Immunol. 140: 487-496. *
Ciccocioppo R, Rossi M, Pesce I, Ricci G, Millimaggi D, Maurano F, Corazza GR 2008 Effects of gliadin stimulation on bone marrow-derived dendritic cells from HLA-DQ8 transgenic MICE. Dig. Liver Dis. Jun 20 [Epub ahead of print].
Cijevschi C, Mihai C, Zbranca E, Gogalniceanu P 2005 Osteoporosis in liver cirrhosis. Rom. J. Gastroenterol. 14: 337-341. *
Cimmino MA 2006 Does magnetic resonance represent the gold-standard of imaging for the follow-up of arthritis? Reumatismo 58: 245-252.
Cina RA, Wikiel KJ, Lee PW, Cameron AM, Hettiarachy S, Rowland H, Goodrich J, Colby C, Spitzer TR, Neville DM Jr, Huang CA 2006 Stable multilineage chimerism without graft versus host disease following nonmyeloablative haploidentical hematopoietic cell transplantation. Transplantation 81: 1677-1685.
Cirillo M, Iudici M, Marcarelli F, Laudato M, Zincone F 2008 Nephrolithiasis in patients with intestinal diseases. G. Ital. Nefrol. 25: 42-48.
Clavel G, Bessis N, Lemeiter D, Fardellone P, Mejjad O, Menard JF, Pouplin S, Boumier P, Vittecoq O, Le Loet X, Boissier MC 2007 Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction. Clin. Immunol. 124: 158-164. *
Coates LC, Anderson RR, Fitzgerald O, Gottlieb AB, Kelly SG, Lubrano E, McGonagle DG, Olivieri I, Ritchlin CT, Tan AL, De Vlam K, Helliwell PS 2008 Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review. J. Rheumatol. 35: 1438-1442.
Coghlan MJ, Jacobson PB, Lane B, Nakane M, Lin CW, Elmore SW, Kym PR, Luly JR, Carter GW, Turner R, Tyree CM, Hu J, Elgort M, Rosen J, Miner JN 2003 A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects. Mol. Endocrinol. 17: 860-869. *
Cohen Jr MM 2006 The new bone biology: pathologic, molecular, and clinical correlates. Am. J. Med. Genet. A. 140: 2646-2706.
Cohen SL, Moore AM, Ward WE 2005 Flaxseed oil and inflammation-associated bone abnormalities in interleukin-10 knockout mice. J. Nutr. Biochem. 16: 368-374. *
Cohran VC, Griffiths M, Heubi JE 2008 Bone mineral density in children exposed to chronic glucocorticoid therapy. Clin. Pediatr. (Phila.) 47: 469-475.
Cohran VC, Heubi JE 2003 Treatment of pediatric cholestatic liver disease. Curr. Treat. Options Gastroenterol. 6: 403-415.
Colbert RA, Deodhar AA, Khan MA, Lories RJ, Maksymowych WP, Reveille JD, Ritchlin CT, Rosenbaum JT, Targan SR, Weisman M, Clegg DO 2008 2007 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). J. Rheumatol. 35: 1398-1402.
Colina M, Lo Monaco A, Khodeir M, Trotta F 2007 Propionibacterium acnes and SAPHO syndrome: a case report and literature review. Clin. Exp. Rheumatol. 25: 457-460.
Colonna L, Dinnall JA, Shivers DK, Frisoni L, Caricchio R, Gallucci S 2006 Abnormal costimulatory phenotype and function of dendritic cells before and after the onset of severe murine lupus. Arthritis Res. Ther. 8: R49. *
Comaru-Schally AM, Schally AV 2005 A clinical overview of carcinoid tumors: perspectives for improvement in treatment using peptide analogs (review). Int. J. Oncol. 26: 301-309.
Comcowich SA, Spitzer TR, Tsunoda SM 1997 Ursodiol to prevent hepatic venoocclusive disease. Ann. Pharmacother. 31: 1249-1252.
Compeyrot-Lacassagne S, Tyrrell PN, Atenafu E, Doria AS, Stephens D, Gilday D, Silverman ED 2007 Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus. Arthritis Rheum. 56: 1966-1973. *
Compston JE 2002 Can biochemical markers be used to screen patients with inflammatory bowel disease for osteoporosis? Eur. J. Gastroenterol. Hepatol. 14: 587-589.
Compston JE, Crowe JP, Wells IP, Horton LW, Hirst D, Merrett AL, Woodhead JS, Williams R 1980 Vitamin D prophylaxis and osteomalacia in chronic cholestatic liver disease. Dig. Dis. Sci. 25: 28-32.
Comte D, Lamy O, Schwab M 2007 A rare cause of cervical adenopathy. Schweiz. Rundsch. Med. Prax. 96: 1821-1824.
Connell WR, Kamm MA, Ritchie JK, Lennard-Jones JE 1993 Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut 34: 1081-1085. *
Conway SP, Oldroyd B, Brownlee KG, Wolfe SP, Truscott JG 2008 A cross-sectional study of bone mineral density in children and adolescents attending a cystic fibrosis centre. J. Cyst. Fibros. Jun 21 [Epub ahead of print].
Copland DA, Calder CJ, Raveney BJ, Nicholson LB, Phillips J, Cherwinski H, Jenmalm M, Sedgwick JD, Dick AD 2007 Monoclonal antibody-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis. Am. J. Pathol. 171: 580-598. *
Corazza GR, Stefano MD, Maurino E, Bai JC 2005 Bones in coeliac disease: diagnosis and treatment. Best Pract. Res. Clin. Gastroenterol. 19: 453-465.
Cortes-Hernandez J, Fossati-Jimack L, Petry F, Loos M, Izui S, Walport MJ, Cook HT, Botto M 2004 Restoration of C1q levels by bone marrow transplantation attenuates autoimmune disease associated with C1q deficiency in mice. Eur. J. Immunol. 34: 3713-3722. *
Costello P, FitzGerald O 2001 Disease mechanisms in psoriasis and psoriatic arthritis. Curr. Rheumatol. Rep. 3: 419-427.
Coury F, Annels N, Rivollier A, Olsson S, Santoro A, Speziani C, Azocar O, Flacher M, Djebali S, Tebib J, Brytting M, Egeler RM, Rabourdin-Combe C, Henter JI, Arico M, Delprat C 2008 Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat. Med. 14: 81-87. *
Couzin J 2006 Biomedical research. Bone disease gene finally found. Science 312: 514-515. *
Cozzi F, Podswiadek M, Cardinale G, Oliviero F, Dani L, Sfriso P, Punzi L 2007 Mud-bath treatment in spondylitis associated with inflammatory bowel disease - a pilot randomised clinical trial. Joint Bone Spine 74: 436-439.
Craig RM, Traynor A, Oyama Y, Burt RK 2003 Hematopoietic stem cell transplantation for severe Crohn's disease. Bone Marrow Transplant. 32 Suppl. 1: S57-S59. *
Crane AM, Bradbury L, van Heel DA, McGovern DP, Brophy S, Rubin L, Siminovitch KA, Wordsworth BP, Calin A, Brown MA 2002 Role of NOD2 variants in spondylarthritis. Arthritis Rheum. 46: 1629-1633. *
Crawford BA, Labio ED, Strasser SI, McCaughan GW 2006 Vitamin D replacement for cirrhosis-related bone disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 689-699. *
Crippin JS, Jorgensen RA, Dickson ER, Lindor KD 1994 Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment. Am. J. Gastroenterol. 89: 47-50.
Cuffari C, Li DY, Mahoney J, Barnes Y, Bayless TM 2004 Peripheral blood mononuclear cell DNA 6-thioguanine metabolite levels correlate with decreased interferon-gamma production in patients with Crohn's disease on AZA therapy. Dig. Dis. Sci. 49: 133-137. *
Cuthbert JA, Pak CY, Zerwekh JE, Glass KD, Combes B 1984 Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia. Hepatology 4: 1-8.
Czaja AJ 2006 Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a foray across diagnostic boundaries. J. Hepatol. 44: 251-252. *
Czaja AJ 2004 Autoimmune liver disease. Curr. Opin. Gastroenterol. 20: 231-240.
D�Haens G 2005 Pratical use of steroids in IBD. Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, p. 30. *
Dahlke MH, Popp FC, Larsen S, Schlitt HJ, Rasko JE 2004 Stem cell therapy of the liver - fusion or fiction? Liver Transpl. 10: 471-479. *
Daikeler T, Kotter I, Bocelli Tyndall C, Attarbaschi A, Apperley J, Guardiola P, Gratwohl A, Jantunen E, Marmont A, Porretto F, Musso M, Maurer B, Rinaldi N, Saccardi R, Tyndall A 2007 Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis. A retrospective analysis of patients recorded to the European Bone Marrow Transplantation (EBMT) and European League Against Rheumatism (EULAR) � Ann. Rheum. Dis. 66: 202-207. *
Dalamaga M, Karmaniolas K, Matekovits A, Migdalis I, Papadavid E 2008 Cutaneous manifestations in relation to immunologic parameters in a cohort of primary myelodysplastic syndrome patients. J. Eur. Acad. Dermatol. Venereol. 22: 543-548.
Damiani D, Tiribelli M, Raspadori D, Michelutti A, Gozzetti A, Calistri E, Candoni A, Chiarvesio A, Lenoci M, Russo D, Fanin R 2007 The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype. Hematol. Oncol. 25: 38-43.
Damore M, Minenna G, D'Amore S 2005 Adverse events in rheumatoid arthritis patient with etanercept therapy: the appearance of osteomalacia. Recenti Prog. Med. 96: 552-555.
Dan YY, Yeoh GC 2008 Liver stem cells: a scientific and clinical perspective. J. Gastroenterol. Hepatol. 23: 687-698. *
Dang ZC, Lowik C 2005 Dose-dependent effects of phytoestrogens on bone. Trends Endocrinol. Metab. 16: 207-213. *
Daniel C, Radeke HH, Sartory NA, Zahn N, Zuegel U, Steinmeyer A, Stein JM 2006 The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates Th1-mediated colitis in mice. J. Pharmacol. Exp. Ther. 319: 622-631. *
Danielsson A, Lorentzon R, Larsson SE 1982 Intestinal absorption and 25-hydroxylation of vitamin D in patients with primary biliary cirrhosis. Scand. J. Gastroenterol. 17: 349-355.
Darlow SJ, Mandal A, Pick B, Thomas T, Mayberry JF, Robinson RJ 2004 The short-term effects of Eudragit-L-coated prednisolone metasulphobenzoate (Predocol) on bone formation and bone mineral density in acute ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 16: 1173-1176.
Daroszewska A, Ralston SH 2005 Genetics of Paget's disease of bone. Clin. Sci. (Lond.) 109: 257-263. *
Dasilva AG, Yong VW 2008 Expression and regulation of matrix metalloproteinase-12 in experimental autoimmune encephalomyelitis and by bone marrow derived macrophages in vitro. J. Neuroimmunol. 199: 24-34.
Davis J, Chinen J, Garafalo M, Woltz P, Malech H, Puck J 2005 Clinical picture of boys with XSCID and the road to gene therapy. Nurs. Health Sci. 7: 144.
Davis KA, Finger DR, Shparago NI 2002 Disseminated histoplasmosis mimicking Felty's syndrome. J. Clin. Rheumatol. 8: 38-43.
Dawidowicz K, Ea HK, Lahalle S, Qubaja M, Liote F 2008 Unexplained polyarthralgia and celiac disease. Joint Bone Spine 75: 325-328.
Day MJ 2008 Canine sino-nasal aspergillosis: parallels with human disease. Med. Mycol. Jun 26 [Epub ahead of print]. *
Dayer E, Dayer JM, Roux-Lombard P 2007 Primer: the practical use of biological markers of rheumatic and systemic inflammatory diseases. Nat. Clin. Pract. Rheumatol. 3: 512-520. *
Dayer JM 2002 Evidence for the biological modulation of IL-1 activity: the role of IL-1Ra. Clin. Exp. Rheumatol. 20 (5 Suppl. 27): S14-S20.
Dazzi F, van Laar JM, Cope A, Tyndall A 2007 Cell therapy for autoimmune diseases. Arthritis Res. Ther. 9: 206. *
de Boer NK, van Bodegraven AA, de Graaf P, van der Hulst RW, Zoetekouw L, van Kuilenburg AB 2008 Paradoxical elevated thiopurine S-methyltransferase activity after pancytopenia during azathioprine therapy: potential influence of red blood cell age. Ther. Drug Monit. 30: 390-393.
de Buys P, Khanna D, Furst DE 2005 Hemopoietic stem cell transplantation in rheumatic diseases-an update. Autoimmun. Rev. 4: 442-449.
De Franco S, Chiocchetti A, Ferretti M, Castelli L, Cadario F, Cerutti F, Rabbone I, Indelicato M, Mazzarino C, Chessa M, Bona G, Dianzani U 2007 Defective function of the Fas apoptotic pathway in type 1 diabetes mellitus correlates with age at onset. Int. J. Immunopathol. Pharmacol. 20: 567-576.
De La Rue SA, Bickston SJ 2006 Evidence-based medications for the treatment of the inflammatory bowel diseases. Curr. Opin. Gastroenterol. 22: 365-369.
de Medeiros BC, Lacerda MA, Telles JE, da Silva JA, de Medeiros CR 1998 Cholestasis secondary to Hodgkin's disease: report of 2 cases of vanishing bile duct syndrome. Haematologica 83: 1038-1040. *
De Quatrebarbes J, Cordel N, Bravard P, Lenormand B, Joly P 2004 Miescher's cheilitis and lymphocytic clonal expansion: 2 cases. Ann. Dermatol. Venereol. 131: 55-57.
De Re V, Caggiari L, De Vita S, Mazzaro C, Lenzi M, Galli M, Monti G, Ferri C, Zignego AL, Gabrielli A, Sansonno D, Dammacco F, Libra M, Sacchi N, Talamini R, Spina M, Cannizzaro R, Guidoboni M, Dolcetti R 2007 Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. Dig. Liver Dis. 39 Suppl. 1: S65-S71.
De Vita S, Boiocchi M, Sorrentino D, Carbone A, Avellini C, Dolcetti R, Marzotto A, Gloghini A, Bartoli E, Beltrami CA, Ferraccioli G 1997 Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjogren's syndrome. Arthritis Rheum. 40: 318-331.
Dear KL, Compston JE, Hunter JO 2001 Treatments for Crohn's disease that minimise steroid doses are associated with a reduced risk of osteoporosis. Clin. Nutr. 20: 541-546.
Decaens T, Maitre S, Marfaing A, Naveau S, Chaput JC, Mathurin P 2004 Inflammatory bowel disease and latent thrombocythemia: a novel cause of hepatic vein thrombosis. Gastroenterol. Clin. Biol. 28: 394-397.
Demerjian-Somogyi N, Palazzo E, Cohen-Solal M 2005 Osteoporosis in patients with inflammatory bowel disease. Joint Bone Spine 72: 354-356.
Der G, Love T, Schreck J, Horn M 2005 Primary sclerosing cholangitis: a case presentation. Gastroenterol. Nurs. 28: 13-16. *
Deroo BJ, Korach KS 2006 Estrogen receptors and human disease. J. Clin. Invest. 116: 561-570. *
Dewit O, Vanheuverzwyn R, Desager JP, Horsmans Y 2002 Interaction between azathioprine and aminosalicylates: an in vivo study in patients with Crohn's disease. Aliment. Pharmacol. Ther. 16: 79-85. *
Dharancy S, Talbodec N, Asselah T, Hachulla E, Delaporte E, Cortot A, Colombel JF 1998 The synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome, a rare extra-digestive manifestation of Crohn's disease. Presentation of 1 case and review of the literature. Gastroenterol. Clin. Biol. 22: 240-243.
Dhawan SS, Finks AL, Wang BW 2008 Mycobacterial coxitis masked by concomitant staphylococcal infection after infliximab for Crohn's disease. Joint Bone Spine Jul 30 [Epub ahead of print].
Di Bisceglie AM, Loyet M, Peters M 2004 Long term follow up of bone mineral density in patients with primary biliary cirrhosis. Minerva Med. 95: 529-534.
Dickey W, Kearney N 2006 Overweight in celiac disease: prevalence, clinical characteristics, and effect of a gluten-free diet. Am. J. Gastroenterol. 101: 2356-2359. *
Dickinson AM, Middleton PG, Rocha V, Gluckman E, Holler E; Eurobank members 2004 Genetic polymorphisms predicting the outcome of bone marrow transplants. Br. J. Haematol. 127: 479-490. *
Dieckgraefe BK, Korzenik JR 2002 Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor. Lancet 360: 1478-1480. *
Dieude P, Cornelis F 2005 Genetic basis of rheumatoid arthritis. Joint Bone Spine 72: 520-526.
Dinca M, Fries W, Luisetto G, Peccolo F, Bottega F, Leone L, Naccarato R, Martin A 1999 Evolution of osteopenia in inflammatory bowel disease. Am. J. Gastroenterol. 94: 1292-1297. *
Diniz-Santos DR, Brandao F, Adan L, Moreira A, Vicente EJ, Silva LR 2008 Bone mineralization in young patients with type 1 diabetes mellitus and screening-identified evidence of celiac disease. Dig. Dis. Sci. 53: 1240-1245. *
Djukic M, Mildner A, Schmidt H, Czesnik D, Bruck W, Priller J, Nau R, Prinz M 2006 Circulating monocytes engraft in the brain, differentiate into microglia and contribute to the pathology following meningitis in mice. Brain 129: 2394-2403. *
Djuric Z, Kamenov B, Katic V 2007 Celiac disease manifested by polyneuropathy and swollen ankles. World J. Gastroenterol. 13: 2636-2638. *
Dogan RN, Elhofy A, Karpus WJ 2008 Production of CCL2 by central nervous system cells regulates development of murine experimental autoimmune encephalomyelitis through the recruitment of TNF- and iNOS-expressing macrophages and myeloid dendritic cells. J. Immunol. 180: 7376-7384.
Dominguez-Soto A, Corbi AL 2007 Myeloid dendritic cell lectins and their role in immune responses. Curr. Opin. Investig. Drugs 8: 910-920.
Dong J, Huang ZW, Piao JH, Gong J 2006 Association of bone mineral density with gene polymorphisms and environmental factors in Chinese postmenopausal women. Wei Sheng Yan Jiu 35: 196-200.
Douroudis K, Tarassi K, Athanassiades T, Giannakopoulos F, Kominakis A, Thalassinos N, Papasteriades Ch 2007 HLA alleles as predisposal factors for postmenopausal osteoporosis in a Greek population. Tissue Antigens 69: 592-596. *
Dovio A, Perazzolo L, Saba L, Termine A, Capobianco M, Bertolotto A, Angeli A 2006 High-dose glucocorticoids increase serum levels of soluble IL-6 receptor alpha and its ratio to soluble gp130: an additional mechanism for early increased bone resorption. Eur. J. Endocrinol. 154: 745-751. *
Drakes M, Blanchard T, Czinn S 2004 Bacterial probiotic modulation of dendritic cells. Infect. Immun. 72: 3299-3309. *
Dresner-Pollak R, Gelb N, Rachmilewitz D, Karmeli F, Weinreb M 2004 Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones. Gastroenterology 127: 792-801. *
Dresner-Pollak R, Karmeli F, Eliakim R, Ackerman Z, Rachmilewitz D 2000 Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease. Am. J. Gastroenterol. 95: 699-704. *
Duan LN, Han HX, Liu J, Yan HM, Zhu L, Xue M, Ding L, Zhu PY, Wang HX, Ji SQ 2007 Impact of incompatible killer cell immunoglobulin-like receptor and its ligand on the outcome of haploidentical bone marrow transplantation. Zhongguo Shi Yan Xue Ye Xue Za Zhi 15: 809-815.
Dubinsky MC 2004 Diffuse jejunoileitis in adolescence. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 70. May 7-8. *
Dubinsky MC 2003 Optimizing immunomodulator therapy for inflammatory bowel disease. Curr. Gastroenterol. Rep. 5: 506-511.
Dubinsky MC 2006 New patients: should children be treated differently? Colorectal Dis. 8 Suppl. 1: 15-19.
Dubinsky MC, Fleshner PP 2003 Treatment of Crohn's disease of inflammatory, stenotic, and fistulizing phenotypes. Curr. Treat. Options Gastroenterol. 6: 183-200.
Duerr RH 2007 Genome-wide association studies herald a new era of rapid discoveries in inflammatory bowel disease research. Gastroenterology 132: 2045-2049. *
Duet M, Liote F 2004 Somatostatin and somatostatin analog scintigraphy: any benefits for rheumatology patients? Joint Bone Spine 71: 530-535.
Duggan P, O'Brien M, Kiely M, McCarthy J, Shanahan F, Cashman KD 2004 Vitamin K status in patients with Crohn's disease and relationship to bone turnover. Am. J. Gastroenterol. 99: 2178-2185. *
Dunn P, Kuo TT, Shih LY, Lin TL, Wang PN, Kuo MC, Tang CC 2004 Primary salivary gland lymphoma: a clinicopathologic study of 23 cases in Taiwan. Acta Haematol. 112: 203-208.
Dusso AS, Brown AJ, Slatopolsky E 2005 Vitamin D. Am. J. Physiol. Renal Physiol. 289: F8-F28. *
Duvoux C, Kracht M, Lang P, Vernant JP, Zafrani ES, Dhumeaux D 1991 Nodular regenerative hyperplasia of the liver associated with azathioprine therapy. Gastroenterol. Clin. Biol. 15: 968-973.
Dygai AM, Zhdanov VV, Epstein OI, Zyuz'kov GN, Sergeyeva SA, Vetoshkina TV, Fomina TI, Gur'yantseva A, Stavrova LA, Sotnikova NV, Gol'dberg ED 2007 Stem cells in experimental chronic hepatitis. Bull. Exp. Biol. Med. 143: 136-139.
Ebert EC, Nagar M 2008 Gastrointestinal manifestations of amyloidosis. Am. J. Gastroenterol. 103: 776-787. *
Egan LJ, Derijks LJ, Hommes DW 2006 Pharmacogenomics in inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 4: 21-28. *
Eivindson M, Gronbaek H, Flyvbjerg A, Frystyk J, Zimmermann-Nielsen E, Dahlerup JF 2007 The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's disease: relations to disease activity and corticosteroid treatment. Growth Horm. IGF Res. 17: 33-40.
Eivindson M, Gronbaek H, Skogstrand K, Thorsen P, Frystyk J, Flyvbjerg A, Dahlerup JF 2007 The insulin-like growth factor (IGF) system and its relation to infliximab treatment in adult patients with Crohn's disease. Scand. J. Gastroenterol. 42: 464-470. *
El Miedany YM, Ahmed I, Moustafa H, El Baddini M 2004 Hyperprolactinemia in Sjogren's syndrome: a patient subset or a disease manifestation? Joint Bone Spine 71: 203-208.
El Miedany YM, Baddour M, Ahmed I, Fahmy H 2005 Sjogren's syndrome: concomitant H. pylori infection and possible correlation with clinical parameters. Joint Bone Spine 72: 135-141.
El-Badri NS, Maheshwari A, Sanberg PR 2004 Mesenchymal stem cells in autoimmune disease. Stem Cells Dev. 13: 463-472.
el-Sayed Zaki M 2007 Relevance of specific immunoglobulin M and immunoglobulin G for parvovirus B19 diagnosis in patients with acute lymphoblastic leukemia receiving chemotherapy: prospective study. Arch. Pathol. Lab. Med. 131: 1697-1669.
Elkayam O, Caspi D, Reitblatt T, Charboneau D, Rubins JB 2004 The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin. Arthritis Rheum. 33: 283-288. *
Elmaagacli AH, Koldehoff M, Hindahl H, Steckel NK, Trenschel R, Peceny R, Ottinger H, Rath PM, Ross RS, Roggendorf M, Grosse-Wilde H, Beelen DW 2006 Mutations in innate immune system NOD2/CARD15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation. Transplantation 81: 247-254.
Elmaagacli AH, Koldehoff M, Landt O, Beelen DW 2008 Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation. Bone Marrow Transplant. 41: 821-826.
Elson CO 1996 The effects of immunosuppressive agents on cytokines. Aliment. Pharmacol. Ther. 10 Suppl. 2: 100-105.
Enzenauer RJ, West SG 1992 Sarcoidosis in autoimmune disease. Semin. Arthritis Rheum. 22: 1-17.
Epstein E, Kiechle FL, Zak B 1984 Use of alkaline phosphatase isoenzyme analysis in the evaluation of cholestatic liver disease. Ann. Clin. Lab. Sci. 14: 292-297.
Epstein O, Ajdukiewicz AB, Dick R, Sherlock S 1979 Hypertrophic hepatic osteoarthropathy. Clinical, roentgenologic, biochemical, hormonal and cardiorespiratory studies, and review of the literature. Am. J. Med. 67: 88-97.
Epstein O, Dick R, Sherlock S 1981 Prospective study of periostitis and finger clubbing in primary biliary cirrhosis and other forms of chronic liver disease. Gut 22: 203-206. *
Epstein S, Leroith D 2008 Diabetes and fragility fractures - a burgeoning epidemic? Bone 43: 3-6.
Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, Mychaleckyj JC, Todd JA, Bonella P, Fear AL, Lavant E, Louey A, Moonsamy P; for the TIDGC 2008 HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the Type 1 Diabetes Genetics Consortium Families. Diabetes 57: 1084-1092.
Esparza J, Kruse M, Lee J, Michaud M, Madri JA 2004 MMP-2 null mice exhibit an early onset and severe experimental autoimmune encephalomyelitis due to an increase in MMP-9 expression and activity. FASEB J. 18: 1682-1691. *
Esters N, Pierik M, van Steen K, Vermeire S, Claessens G, Joossens S, Vlietinck R, Rutgeerts P 2004 Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease. Am. J. Gastroenterol. 99: 299-305. *
Falchetti A, Sferrazza C, Cepollaro C, Gozzini A, Del Monte F, Masi L, Napoli N, Di Fede G, Cannone V, Cusumano G, Pandolfo MC, Rini GB, Tanini A, Brandi ML 2007 FokI polymorphism of the vitamin D receptor gene correlates with parameters of bone mass and turnover in a female population of the Italian island of Lampedusa. Calcif. Tissue Int. 80: 15-20. *
Fang H, Xie Q, Boneva R, Fostel J, Perkins R, Tong W 2006 Gene expression profile exploration of a large dataset on chronic fatigue syndrome. Pharmacogenomics 7: 429-440.
Fantry L 2002 Gastrointestinal infections in the immunocompromised host. Curr. Opin. Gastroenterol. 18: 34-39.
Farge D 2007 Bone marrow transplantation in the treatment of autoimmune disease. Rev. Med. Interne. 28 Suppl. 4: S285-S287.
Farge D, Marolleau JP, Zohar S, Marjanovic Z, Cabane J, Mounier N, Hachulla E, Philippe P, Sibilia J, Rabian C, Chevret S, Gluckman E; Intensification et Autogreffe dans les Maladies Auto Immunes Resistantes (ISAMAIR) Study Group 2002 Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study. Br. J. Haematol. 119: 726-739.
Farias AQ, Goncalves LL, Cancado EL, Carrilho FJ 2007 Bone disease in primary biliary cirrhosis and renal tubular acidosis. Aliment. Pharmacol. Ther. 25: 1133-1134. *
Farias AQ, Goncalves LL, Cancado EL, Seguro AC, Campos SB, Abrantes-Lemos CP, Carrilho FJ 2005 Bone disease in primary biliary cirrhosis: lack of association with distal renal tubular acidosis. J. Gastroenterol. Hepatol. 20: 147-152. *
Farjadian S, Ghaderi A 2007 HLA class II genetic diversity in Arabs and Jews of Iran. Iran J. Immunol. 4: 85-93.
Farup PG, Hinterleitner TA, Lukas M, Hebuterne X, Rachmilewitz D, Campieri M, Meier R, Keller R, Rathbone B, Oddsson E 2001 Mesalazine 4 g daily given as prolonged-release granules twice daily and four times daily is at least as effective as prolonged-release tablets four times daily in patients with ulcerative colitis. Inflamm. Bowel Dis. 7: 237-242. *
Fassas A, Passweg JR, Anagnostopoulos A, Kazis A, Kozak T, Havrdova E, Carreras E, Graus F, Kashyap A, Openshaw H, Schipperus M, Deconinck E, Mancardi G, Marmont A, Hansz J, Rabusin M, Zuazu Nagore FJ, Besalduch J, Dentamaro T, Fouillard L, et al 2002 Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. J. Neurol. 249: 1088-1097.
Faubion WA, De Jong YP, Molina AA, Ji H, Clarke K, Wang B, Mizoguchi E, Simpson SJ, Bhan AK, Terhorst C 2004 Colitis is associated with thymic destruction attenuating CD425 regulatory T cells in the periphery. Gastroenterology 126: 1759-1770. *
Faulds D, Goa KL, Benfield P 1993 Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs 45: 953-1040.
Faust D, Menge F, Armbruster FP, Lembcke B, Stein J 2003 Increased serum bone sialoprotein concentrations in patients with Crohn's disease. Z. Gastroenterol. 41: 243-247.
Fazzo L, Belli S, Minichilli F, Mitis F, Santoro M, Martina L, Pizzuti R, Comba P, Martuzzi M, Bianchi F 2008 Cluster analysis of mortality and malformations in the provinces of Naples and Caserta (Campania Region). Ann. Ist Super Sanita 44: 99-111.
Federzoni E, Gordon G, Muller S, Schmid I, Simon HU, Yousefi S 2008 Expression of CD95 on mature leukocytes of MRL/lpr mice after transplantation of genetically modified bone marrow stem cells. Immunol. Lett. 117: 45-49.
Fedorak RN, Madsen KL 2004 Probiotics and the management of inflammatory bowel disease. Inflamm. Bowel Dis. 10: 286-299. *
Feig C, Peter ME 2007 How apoptosis got the immune system in shape. Eur. J. Immunol. 37 Suppl. 1: 61-70. *
Feldmann M, Maini RN 2001 Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu. Rev. Immunol. 19: 163-196. *
Feldstein AC, Elmer PJ, Nichols GA, Herson M 2005 Practice patterns in patients at risk for glucocorticoid-induced osteoporosis. Osteoporos. Int. 16: 2168-2174. *
Feng X, Li H, Rumbin AA, Wang X, La Cava A, Brechtelsbauer K, Castellani LW, Witztum JL, Lusis AJ, Tsao BP 2007 ApoE-/-Fas-/-C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis and osteopenia. J. Lipid Res. 48: 794-805. *
Feofanova NA, Toporkova LB, Tikhonova MA, Nevinskii GA, Kozlov VA, Orlovskaya IA 2006 Cell cycle of bone marrow CD34+ cells during autoimmune disease development in MRLMpJ/lpr mice. Bull. Exp. Biol. Med. 142: 137-139.
Fernandes G 2008 Progress in nutritional immunology. Immunol. Res. 40: 244-261.
Ferrari S, Bonjour JP, Rizzoli R 1998 The vitamin D receptor gene and calcium metabolism. Trends Endocrinol. Metab. 9: 259-265. *
Fevery S, Billiau AD, Sprangers B, Rutgeerts O, Lenaerts C, Goebels J, Landuyt W, Kasran A, Boon L, Sagaert X, De Wolf-Peeters C, Waer M, Vandenberghe P 2007 CTLA-4 blockade in murine bone marrow chimeras induces a host-derived antileukemic effect without graft-versus-host disease. Leukemia 21: 1451-1459.
Fewtrell MS, Benden C, Williams JE, Chomtho S, Ginty F, Nigdikar SV, Jaffe A 2008 Undercarboxylated osteocalcin and bone mass in 8-12 year old children with cystic fibrosis. J. Cyst. Fibros. 7: 307-312.
Findlay DM, Haynes DR 2005 Mechanisms of bone loss in rheumatoid arthritis. Mod. Rheumatol. 15: 232-240.
Finesilver AG 2003 Newer approaches to the treatment of rheumatoid arthritis. WMJ 102: 34-37.
Fink S, Schilsky ML 2007 Inherited metabolic disease of the liver. Curr. Opin. Gastroenterol. 23: 237-243.
Fiore CE, Pennisi P, Ferro G, Ximenes B, Privitelli L, Mangiafico RA, Santoro F, Parisi N, Lombardo T 2006 Altered osteoprotegerin/RANKL ratio and low bone mineral density in celiac patients on long-term treatment with gluten-free diet. Horm. Metab. Res. 38: 417-422.
Firouzi F, Rashidi M, Hashemi S, Kangavari M, Bahari A, Daryani NE, Emam MM, Naderi N, Shalmani HM, Farnood A, Zali M 2007 A decision tree-based approach for determining low bone mineral density in inflammatory bowel disease using WEKA software. Eur. J. Gastroenterol. Hepatol. 19: 1075-1081.
Fishbein T, Novitskiy G, Mishra L, Matsumoto C, Kaufman S, Goyal S, Shetty K, Johnson L, Lu A, Wang A, Hu F, Kallakury B, Lough D, Zasloff M 2008 NOD2-expressing bone marrow-derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine. Gut 57: 323-330. *
Fitzpatrick LA 2002 Secondary causes of osteoporosis. Mayo Clin. Proc. 77: 453-468. *
Flierman R, Witteveen HJ, van der Voort EI, Huizinga TW, de Vries RR, Fibbe WE, Toes RE, van Laar JM 2005 Control of systemic B cell-mediated autoimmune disease by nonmyeloablative conditioning and MHC-mismatched allogeneic bone marrow transplantation. Blood 105: 2991-2994. *
Floreani A, Mega A, Camozzi V, Baldo V, Plebani M, Burra P, Luisetto G 2005 Is osteoporosis a peculiar association with primary biliary cirrhosis? World J. Gastroenterol. 11: 5347-5350. *
Fonseca V, Epstein O, Gill DS, Menon RK, Thomas M, McIntyre N, Dandona P 1987 Hyperparathyroidism and low serum osteocalcin despite vitamin D replacement in primary biliary cirrhosis. J. Clin. Endocrinol. Metab. 64: 873-877.
Forbes GM, Jeffrey GP, Shilkin KB, Reed WD 1992 Carbamazepine hepatotoxicity: another cause of the vanishing bile duct syndrome. Gastroenterology 102: 1385-1388.
Forbes SJ, Russo FP, Rey V, Burra P, Rugge M, Wright NA, Alison MR 2004 A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 126: 955-963. *
Fostel J, Boneva R, Lloyd A 2006 Exploration of the gene expression correlates of chronic unexplained fatigue using factor analysis. Pharmacogenomics 7: 441-454.
Foti R, Leonardi R, Rondinone R, Di Gangi M, Leonetti C, Canova M, Doria A 2008 Scleroderma-like disorders. Autoimmun. Rev. 7: 331-339.
Fournier C 2005 Where do T cells stand in rheumatoid arthritis? Joint Bone Spine 72: 527-532.
Fowlkes JL, Bunn RC, Liu L, Wahl EC, Coleman HN, Cockrell